Teva Pharmaceutical Industries Limited (TEVA)
NYSE: TEVA · Real-Time Price · USD
31.50
+0.45 (1.45%)
At close: Mar 9, 2026, 4:00 PM EDT
31.50
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:52 PM EDT
Teva Pharmaceutical Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 36,686 | 35,807 | 25,006 | 11,703 | 10,129 | 8,835 | |
| Market Cap Growth | 90.33% | 43.19% | 113.68% | 15.54% | 14.65% | -16.46% | |
| Enterprise Value | 49,487 | 50,699 | 41,281 | 30,334 | 30,275 | 31,945 | |
| Last Close Price | 31.05 | 31.21 | 22.04 | 10.44 | 9.12 | 8.01 | |
| PE Ratio | 25.66 | 25.40 | - | - | - | 21.19 | |
| Forward PE | 11.58 | 12.07 | 8.35 | 4.21 | 3.63 | 3.02 | |
| PS Ratio | 2.08 | 2.08 | 1.51 | 0.74 | 0.68 | 0.56 | |
| PB Ratio | 4.51 | 4.52 | 4.37 | 1.44 | 1.18 | 0.79 | |
| P/FCF Ratio | 31.20 | 31.19 | 33.39 | 13.90 | 9.72 | 37.44 | |
| P/OCF Ratio | 21.72 | 21.71 | 20.05 | 8.56 | 6.37 | 11.07 | |
| PEG Ratio | 10.30 | 1.82 | 6.69 | 0.40 | 1.63 | 0.68 | |
| EV/Sales Ratio | 2.87 | 2.94 | 2.50 | 1.91 | 2.03 | 2.01 | |
| EV/EBITDA Ratio | 9.99 | 10.23 | 9.31 | 6.99 | 7.63 | 7.25 | |
| EV/EBIT Ratio | 12.52 | 12.83 | 12.24 | 9.52 | 11.37 | 10.38 | |
| EV/FCF Ratio | 43.11 | 44.16 | 55.12 | 36.03 | 29.06 | 135.36 | |
| Debt / Equity Ratio | 2.18 | 2.18 | 3.18 | 2.50 | 2.52 | 2.10 | |
| Debt / EBITDA Ratio | 3.39 | 3.39 | 3.98 | 4.53 | 5.26 | 5.19 | |
| Debt / FCF Ratio | 15.01 | 15.01 | 24.28 | 24.08 | 20.80 | 99.97 | |
| Net Debt / Equity Ratio | 1.73 | 1.73 | 2.60 | 2.10 | 2.19 | 1.91 | |
| Net Debt / EBITDA Ratio | 2.76 | 2.76 | 3.36 | 3.93 | 4.75 | 4.86 | |
| Net Debt / FCF Ratio | 11.91 | 11.91 | 19.87 | 20.25 | 18.11 | 90.80 | |
| Asset Turnover | 0.43 | 0.43 | 0.40 | 0.36 | 0.33 | 0.32 | |
| Inventory Turnover | 2.69 | 2.69 | 2.41 | 2.09 | 2.08 | 2.02 | |
| Quick Ratio | 0.54 | 0.54 | 0.50 | 0.54 | 0.57 | 0.61 | |
| Current Ratio | 1.04 | 1.04 | 0.98 | 1.02 | 1.05 | 1.14 | |
| Return on Equity (ROE) | 20.79% | 20.79% | -28.30% | -7.36% | -25.19% | 4.09% | |
| Return on Assets (ROA) | 6.17% | 6.17% | 5.09% | 4.55% | 3.63% | 3.91% | |
| Return on Invested Capital (ROIC) | 18.07% | 18.73% | 14.74% | 12.10% | 8.85% | 6.18% | |
| Return on Capital Employed (ROCE) | 14.50% | 14.50% | 12.70% | 10.20% | 8.20% | 8.40% | |
| Earnings Yield | 3.94% | 3.94% | -6.55% | -4.78% | -24.15% | 4.72% | |
| FCF Yield | 3.21% | 3.21% | 3.00% | 7.20% | 10.29% | 2.67% | |
| Buyback Yield / Dilution | -2.83% | -2.83% | -1.07% | -0.81% | -0.27% | -1.10% | |
| Total Shareholder Return | -2.83% | -2.83% | -1.07% | -0.81% | -0.27% | -1.10% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.